Aflac (AFL) Stock Overview
Through its subsidiaries, provides supplemental health and life insurance products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
AFL Community Fair Values
Create NarrativeSee what 49 others think this stock is worth. Follow their fair value or set your own to get alerts.
Aflac Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$102.88 |
| 52 Week High | US$115.50 |
| 52 Week Low | US$88.00 |
| Beta | 0.80 |
| 1 Month Change | -0.77% |
| 3 Month Change | 3.12% |
| 1 Year Change | 16.22% |
| 3 Year Change | 83.58% |
| 5 Year Change | 194.95% |
| Change since IPO | 172,868.61% |
Recent News & Updates
Recent updates
Aflac: Steady Compounding At Fair Value
May 31Aflac Incorporated Just Missed Earnings - But Analysts Have Updated Their Models
May 03
Benign Growth For Aflac Incorporated (NYSE:AFL) Underpins Its Share Price
Apr 27Aflac's Shares Are Overvalued
Jan 08Aflac (NYSE:AFL) Is Paying Out A Larger Dividend Than Last Year
Jan 08Aflac (NYSE:AFL) Has Announced That It Will Be Increasing Its Dividend To $0.58
Dec 19Aflac Incorporated (NYSE:AFL) Looks Inexpensive But Perhaps Not Attractive Enough
Dec 12Insurer Aflac Quacks Away At Policy Growth And Low Debt Risk
Nov 02Aflac: Double Digit Dividend Growth And Strong Portfolio Of Investments
Aug 26Should You Be Adding Aflac (NYSE:AFL) To Your Watchlist Today?
Aug 22Aflac Incorporated's (NYSE:AFL) Shares Lagging The Market But So Is The Business
Jul 11Aflac Incorporated: Good Positioning But Risks From Japan
Apr 22Aflac: Growing Cancer Cases Will Lead To Higher Revenues
Apr 09Aflac: A Dividend Aristocrat To Watch
Feb 08Aflac: Still A Very Interesting Dividend-Growth Play
Jan 17Aflac: Should Be Part Of Any Dividend Growth Portfolio
Dec 19Aflac Q3: Why High Valuation May Be Signaling A Stock Split (Rating Upgrade)
Dec 05Aflac: Hold Rating Reaffirmed, A Dividend Grower With High Stock Price
Nov 08Aflac: An Incredible Dividend Aristocrat That Every Dividend Investor Should Own
Oct 03Insurer Aflac Swims On In Strong Rate Environment, But Remains Overbought
Jun 19Shareholder Returns
| AFL | US Insurance | US Market | |
|---|---|---|---|
| 7D | -2.4% | -2.4% | 0.4% |
| 1Y | 16.2% | 14.5% | 12.5% |
Return vs Industry: AFL matched the US Insurance industry which returned 16.4% over the past year.
Return vs Market: AFL exceeded the US Market which returned 13.7% over the past year.
Price Volatility
| AFL volatility | |
|---|---|
| AFL Average Weekly Movement | 3.2% |
| Insurance Industry Average Movement | 4.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 3.7% |
Stable Share Price: AFL has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: AFL's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1955 | 12,694 | Dan Amos | www.aflac.com |
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan.
Aflac Incorporated Fundamentals Summary
| AFL fundamental statistics | |
|---|---|
| Market cap | US$56.54b |
| Earnings (TTM) | US$3.59b |
| Revenue (TTM) | US$16.89b |
Is AFL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFL income statement (TTM) | |
|---|---|
| Revenue | US$16.89b |
| Cost of Revenue | US$9.22b |
| Gross Profit | US$7.67b |
| Other Expenses | US$4.08b |
| Earnings | US$3.59b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 05, 2025
| Earnings per share (EPS) | 6.65 |
| Gross Margin | 45.41% |
| Net Profit Margin | 21.27% |
| Debt/Equity Ratio | 42.1% |
How did AFL perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/07 01:47 |
| End of Day Share Price | 2025/07/07 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aflac Incorporated is covered by 34 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Taylor Scott | Barclays |
| Jay Gelb | Barclays |